×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SESSION 6 : Development of Cell and Gene Therapy in Asia
Session Chair(s)
Sumimasa Nagai, MD, PhD
Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan
Yoshie Tsurumaki
Group Manager, Cell & Gene Franchise
Novartis Pharma K.K., Japan
Speaker(s)
Activity of APACRM WG1: Non-clinical
Hiroshi Karasawa
Daiichi Sankyo Co.,Ltd., Japan
Cell Therapy Research Labs
APACRM working group activity; WG2:Quality
Toshimitsu Tanaka
Astellas Pharma Inc., Japan
Senior Manager, CMC Regulatory Affairs
Development of Cell and Gene Therapy in China
Yunhong Huang
Center for Drug Evaluation, National Medical Products Administration, China
PMDA Perspective : Regulatory Convergence on Regenerative Medicine
Yoshiaki Maruyama, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of Cellular and Tissue-based Products
Have an account?